JMSLtd Valuation

Q: What is the Fair Price of 7702 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

7702 (¥445) is trading above our estimate of [[fair value]] (¥350.99)

Is 7702 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7702 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7702 (¥445) is trading above our estimate of fair value (¥350.99)

Significantly Below Fair Value: 7702 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7702?

Key metric: As 7702 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 7702. This is calculated by dividing 7702's market cap by their current revenue.
What is 7702's PS Ratio?
PS Ratio	0.2x
Sales	JP¥67.87b
Market Cap	JP¥10.85b

7702 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.4x
Enterprise Value/EBITDA	6.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 7702's PS Ratio compare to its peers?

The above table shows the PS ratio for 7702 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.5x
7743 SEEDLtd	0.4x	7.6%	JP¥14.1b
5187 Create Medic	0.6x	n/a	JP¥7.9b
7963 Koken	0.8x	n/a	JP¥7.7b
3604 Kawamoto	0.1x	n/a	JP¥4.6b
7702 JMSLtd	0.2x	n/a	JP¥10.8b

Price-To-Sales vs Peers: 7702 is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (0.5x).

Price to Sales Ratio vs Industry

How does 7702's PS Ratio compare vs other companies in the JP Medical Equipment Industry?

2 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.6x	6.5%
7702 JMSLtd	0.2x	n/a	US$70.04m
3604 Kawamoto	0.1x	n/a	US$29.72m

No more companies available in this PS range

2 Companies		Estimated Growth	Market Cap
Industry Avg.	1.6x	12.8%
7702 JMSLtd	0.2x	n/a	US$70.04m

No more companies

Price-To-Sales vs Industry: 7702 is good value based on its Price-To-Sales Ratio (0.2x) compared to the JP Medical Equipment industry average (1.6x).

Price to Sales Ratio vs Fair Ratio

What is 7702's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7702 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 7702's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

FINDEX

JP¥20.5b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥800.00

-0.5%

-15.3%

Suzuken

JP¥383.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,775.00

0.2%

-4.4%

TOKAI

JP¥74.5b

Provides various healthy life services in Japan.

9729

JP¥2,213.00

0.05%

18.2%